A Reversible Gastric Uptake of Bone Scintigraphy in a Patient with Hypercalcemia.

A Reversible Gastric Uptake of Bone Scintigraphy in a Patient with Hypercalcemia. Intern Med. 2019 Feb 01;: Authors: Fukasawa H, Ide S, Kaneko M, Ishibuchi K, Niwa H, Yasuda H, Furuya R Abstract Hypercalcemia is a severe complication in cases of vitamin D intoxication that can result in metastatic calcification. We herein report a female case with hypercalcemia due to eldecalcitol administration associated with the increased uptake of technetium-99mhydroxymethylene diphosphonate (99mTc-HMDP) as the bone-scanning agent in the stomach. A histologic assessment using biopsy specimens identified metastatic calcification of the stomach. After the normalization of serum calcium levels, the gastric uptake of 99mTc-HMDP disappeared. This case indicates the usefulness of bone scintigraphy with 99mTc-HMDP to detect visceral metastatic calcification and to monitor its therapeutic effects in patients with hypercalcemia. PMID: 30713296 [PubMed - as supplied by publisher]
Source: Internal Medicine - Category: Internal Medicine Tags: Intern Med Source Type: research